| Institution | PI Name | Title |
|---|
| Baylor College of Medicine | George Weinstock | Francisella genomics |
| Benaroya Research Institute at Virginia Mason | Gerald Nepom | MHC tetramers for epitopes of B anthracis PA |
| Brigham and Women's Hospital | Lynn Bry | Protective role of cross-reactive anti-enteric antibody |
| Burnham Institute | Kristina Vuori | Mechanisms of anti-phagocytosis by Yersinia pestis |
| Children's Hospital (Boston) | Nicholas Mantis | Gastrointestinal immunity Ricin |
| Cleveland Clinic Lerner Col/Med-CWRU | Andrew Larner | The effects of interferon on anthrax toxicity |
| Dartmouth College | Surachai Supattapone | Species susceptibility assay for chronic wasting disease |
| Duke University | Richard Frothingham | Alternative endpoints for plague challenge models |
| Duke University | John Hollingsworth | Genetic susceptibility to F. tularensis |
| Eastern Virginia Medical School | Yuping Deng | The response to influenza: aging & vaccine efficacy |
| Emory University | Richard Compans | Development of VLP vaccines for SARS prevention |
| Georgetown University | Radkarkrishnan Padmanabhan | Dengue & west nile viral protease inhibitors |
| Georgetown University | Mitchell Jung | Role of PARP-1 in salmonella pathogenesis |
| Georgia State University | Margo Brinton | Oas-1 gene transgenic mice for WNV research |
| Hauptman-Woodward Medical Research Institute | L. Wayne Schultz | Structural studies of SARS & MHV replicase proteins |
| Henry M. Jackson FDN for the ADV MIL/MED | Anthony Maurelli | Metabolic modeling of invasive bacteria & HeLa Cytosol |
| Iowa State University | James Roth | Nipah virus marker vaccine & companion diagnostic test |
| Johns Hopkins University | Ernst Spannhake | Bronchial epithelial cell costimulation of CD4+ T cells |
| Johns Hopkins University | Robert Gilman | Transmission dynamics of cryptosporidium sp. |
| Kansas State University | George Stewart | Function of the B. anthracis spore carbohydrate |
| La Jolla Institute for Allergy/Immunology | Christopher Benedict | Activation of innate antiviral defenses by LTbetaR |
| Massachusetts General Hospital | Marcia Goldberg | Autotransporter periplasmic chaperones in Shigella |
| Massachusetts General Hospital | Indira Kudva | E. coli 0157:H7 genes induced during human infection |
| Mayo Clinic College of Medicine, Rochester | Marilia Cascalho | Mutable vaccine for biodefense |
| Montana State University, Bozeman | Marcella McClure | A bioinformatic approach to inferring protein contracts |
| National Research Council of Canada | Wangxue Chen | Mouse model of oral infection with virulent Francisella |
| New England Medical Center Hospitals | Jenifer Coburn | Vascular tropism of Borrelia burgdorferi |
| New York University School of Medicine | Yvette Weinrauch | Interaction of enteroinvasive pathogens with neutrophils |
| North Carolina State University, Raleigh | Barbara Sherry | Poxvirus adverse effects on cardiac cells & the heart |
| Northeastern University | Kim Lewis | Novel methods for discovery of antimicrobials |
| Northeastern Univerisity | Kim Lewis | Biodefense therapeutics from uncultured microorganisms |
| Northern Arizona University | Fernando Monroy | Innate intestinal responses in murine toxoplasmosis |
| Oregon Health & Science University | David Johnson | Hantavirus vaccines based on nonreplicating adenoviruses |
| Oregon Health & Science University | Jay Nelson | The role of Src kinase in west nile virus replication |
| Oregon Health & Science University | Jorge Crosa | Iron uptake & virulence of Burkholderia pseudomallei |
| Oregon Health & Science University | Eric Barklis | Analysis of sin nombre virus inhibition in lung cells |
| Oregon State University | Dennis Hruby | Variola virus G1L: an antiviral drug target |
| Public Health Research Institute | Gilla Kaplan | Cytokines in pathogenesis of anthrax infection |
| Rice University | Michael Deem | Modeling of multivalent vaccination for variable viruses |
| Rutgers the State University of New Jersery, New Brunswick | Nilgun Tumer | Mechanism of action of ricin A chain |
| San Diego State University | Anca Segall | Inhibitors of poxvirus holliday junction resolvase |
| Scripps Research Institute | Lisa Craig | Structure & assembly of type IVb Pili |
| Sidney Kimmel Cancer Center | Michael McClelland | ? |
| Southern Research Institute | Ashish Pathak | New adjuvant technologies for a marburg virus vaccine |
| SRI International | Seajin Oh | Transdermal vaccine delivery platform technology |
| St. Jude Children's Research Center | Robert Webster | Combination chemotherapy for pandemic influenza |
| St. Jude Children's Research Center | Stephen White | Development of DHPS as a bioterrorism therapeutic target |
| St. Louis University | Robert Buller | Study of monkeypox virus in rodents |
| St. Louis University | Daniel Hoft | Vaccine induced mucosal protection against TB infection |
| Stanford University | Ronald Davis | Charge-based pathogen DNA detection |
| State University of New York at Buffalo | Edward Niles | Novel inhibitors of poxvirus replication |
| Texas A&M University Health Sciences Center | George Davis | Function of CMG-2, an anthrax toxin receptor |
| Texas A&M University Health Sciences Center | Yi Xu | Cell wall protein in B. anthracis pathogenesis |
| Thomas Jefferson University | Michael Root | Structure of SARS coronavirus spike glycoprotein |
| Thomas Jefferson University | Phyllis Flomenberg | Human T cell responses to vaccinia vaccine |
| Trudeau Institute, Inc. | Robert North | M. bovis as a potentially more virulent MDR pathogen |
| Tufts University | Andrew Bohm | Molecular basis for inhibition of edema factor |
| Tufts University | Matthew Waldor | Role of Hfq in Vibrio cholerae virulence |
| Tufts University, Boston | Naomi Balaban | Quorum sensing & staphylococcus aureus pathogenesis |
| Tufts University, Boston | Giovanni Widmer | Genetic transformation of Cryptosporidium parvum |
| University of Alabama at Birmingham | David Pritchard | B. anthracis peptidoglycan deacatylase as a drug target |
| University of Alabama at Birmingham | John Barr | Investigation of Bunyamwera bunyavirus gene expression |
| University of California, Davis | Paulo Verardi | SMART virus vectors with built-in safety mechanism |
| University of California, Los Angeles | Benhur Lee | A reverse genetic system for the study of Nipah virus |
| University of California, San Diego | Ethan Bier | Genetic analysis of bacterial toxins in drosophila |
| University of California, San Diego | Maurizio Zanetti | Conformationally-constrained PA anthrax vaccine |
| University of California, San Diego | Robert Rickard | C3d-PA: efficacy & cellular basis as an anthrax vaccine |
| University of California, Santa Barbara | Michael Mahan | Epigenetic control of bacterial virulence |
| University of Chicago | David White | Antigen delivery using novel Fc receptor ligands |
| University of Georgia | Julie Coffield | Indentification of Botulinum toxin membrane targets |
| University of Houston | Steven Blanke | C. jejuni cytolethal distending toxin cell interactions |
| University of Iowa | Gregory Gray | Population-based surveillance for zoonotic influenza A |
| University of Kentucky | Susan Straley | Surface proteins in pneumonic plague |
| University of Maryland Baltimore Prof. School | Alexander Sulakvelidze | Genetic clustering & virulence of Y. pestis strains |
| University of Michigan at Ann Arbor | Maria Diakonova | Role of adaptor protein in infectious diseases |
| University of Minnesota, Twin Cities | Mitchell Abrahamsen | Purine salvage in Cryptosporidium parvum |
| University of Montana | Jack Nunberg | Structure-function of junin virus envelope glycoproteins |
| University of Nebraska, Lincoln | Andrew Benson | Genome biology of Francisella tularensis populations |
| University of North Carolina, Chapel Hill | Thomas Kawula | Molecular basis of Francisella virulence and immunity |
| University of North Carolina, Chapel Hill | Janne Cannon | Antigenic variation in F. tularensis |
| University of North Carolina, Chapel Hill | Aravinda De Silva | Interactions between dengue 3 & human dendritic cells |
| University of Pennsylvania | Dieter Schifferli | Function & immunogenicity of Yersinia pestis fimbriae |
| University of Pennsylvania | Ronald Harty | Ebola virus VP40-host interactions in vivo |
| University of Pittsburgh at Pittsburgh | Saleem Khan | Genomics/proteomics of enterotoxin B producing S. aureus |
| University of Pittsburgh at Pittsburgh | Saleem Khan | Plasmid pX02 replication in B. anthracis |
| University of Tennessee, Knoxville | Mark Sangster | Induction of influenza virus-specific memory B cells |
| University of Tennessee Health Sciences Center | George Hilliard | Protein expression in strains of F. tularensis |
| University of Washington | Kelly Hughes | Flagellar phase variation in salmonella |
| University of Wisconsin, Madison | Eric Johnson | Development of genetic tools for Clostridium botulinum |
| Vanderbilt University | Michael Rock | Vaccinia virus-specific T cell phenotypes |
| Vanderbilt University | Richard Peek | Inhibition of pathogen-induced NGkB-mediated inflammation |
| Vanderbilt University | GN Green | Intracellular inhibitors of botulinum neurotoxins |
| Virginia Polytechnic Institute and St. Univ. | David Popham | Spore peptidoglycan degradation in B. anthracis |
| Virginia Polytechnic Institute and St. Univ. | Yongquin He | Gene expression in brucella-infected macrophages |
| Wadsworth Center | David Wentworth | Discovery of a novel promoter in pathogenic influenza |
| Wadsworth Center | Kathleen McDonough | Differential gene expression in Yersinia pestis |
| Wadsworth Center | Paul Masters | SARS coronavirus reverse genetics & pathogenesis |
| Wake Forest University Health Sciences | Kevin High | Brucella, aging & role of IL-17 in host defense |
| Weill Medical College of Cornell University | John Ho | Antigen capture assays for rabid tuberculosis diagnosis |
| Weill Medical College of Cornell University | Richard Granstein | Vaccine development: purinergic agonists as adjuvants |
| Weill Medical College of Cornell University | Julie Boyer | Genetic passive immunotherapy for Shiga toxin |